Emergent BioSolutions (EBS) Tops Q1 EPS by 142c, provides guidanvce
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $6.76 --0%
EPS Growth %: -138.7%
Financial Fact:
Selling, general and administrative: 40.69M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -138.7%
Financial Fact:
Selling, general and administrative: 40.69M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of $0.59, $1.42 better than the analyst estimate of ($0.83). Revenue for the quarter came in at $300.4 million versus the consensus estimate of $185.4 million.
GUIDANCE:
Emergent BioSolutions sees FY2024 revenue of $1-1.1 billion, versus the consensus of $1.015 billion.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cracker Barrel (CBRL) Tops Q4 EPS by 89c, Offers Guidance
- General Mills beats estimates as cost savings offset volumes
- Oppenheimer Starts Amneal Pharmaceuticals (AMRX) at Outperform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
